rs779642265
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_014855.3(AP5Z1):c.2345A>G(p.Asp782Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000248 in 1,612,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_014855.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP5Z1 | NM_014855.3 | c.2345A>G | p.Asp782Gly | missense_variant | Exon 17 of 17 | ENST00000649063.2 | NP_055670.1 | |
AP5Z1 | NM_001364858.1 | c.1877A>G | p.Asp626Gly | missense_variant | Exon 16 of 16 | NP_001351787.1 | ||
AP5Z1 | XM_047421098.1 | c.2009A>G | p.Asp670Gly | missense_variant | Exon 15 of 15 | XP_047277054.1 | ||
AP5Z1 | NR_157345.1 | n.2476A>G | non_coding_transcript_exon_variant | Exon 17 of 17 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000816 AC: 2AN: 244994Hom.: 0 AF XY: 0.00000748 AC XY: 1AN XY: 133774
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1459938Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 726226
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74374
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 48 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with AP5Z1-related disease. This variant is present in population databases (rs779642265, ExAC 0.002%). This sequence change replaces aspartic acid with glycine at codon 782 of the AP5Z1 protein (p.Asp782Gly). The aspartic acid residue is highly conserved and there is a moderate physicochemical difference between aspartic acid and glycine. -
Inborn genetic diseases Uncertain:1
The c.2345A>G (p.D782G) alteration is located in exon 17 (coding exon 17) of the AP5Z1 gene. This alteration results from a A to G substitution at nucleotide position 2345, causing the aspartic acid (D) at amino acid position 782 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at